Thomas Christoph

This inventor holds 37 USPTO granted patents and 28 published patent applications, plus 5 CIPO patents and 21 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Gruenenthal Gmbh, Cambridge Bioclinical Limited, Medifron Dbt Inc.. Active years: 1999-2019.

USPTO Granted Patents = 37 (Patent Applications = 28)

% Patents Active = 24.3

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 21 (Patent Applications = 34)

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 122(Granted Patents)

Company Filing History:

Cambridge Bioclinical Limited

Years Active: 1999-2019

Loading Chart...

Areas of Expertise:

Pharmaceutical Composition

Vanilloid Receptor Ligands

Antidepressants

Gabapentinoids

Neuropathic Pain

Urinary Incontinence

Bicyclic Compounds

Carboxamide Derivatives

Sulfonamide Compounds

Opioids

Phenylureas

Imidazo Compounds

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10328055 - Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indo]-4-amine and antidepressants (2019-06-25),

2. 10206890 - Pharmaceutical combination (2019-02-19),

3. 9771359 - Substituted oxazole- and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands II (2017-09-26),

4. 9629825 - Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid (2017-04-25),

5. 9624209 - Substituted phenylureas and phenylamides as vanilloid receptor ligands (2017-04-18),

6. 9345689 - Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and an anticonvulsant (2016-05-24),

7. 9320725 - Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid (2016-04-26),

8. 9120756 - Substituted phenylureas and phenylamides as vanilloid receptor ligands (2015-09-01),

9. 9029378 - Substituted bicyclic aromatic carboxamide and urea compounds as vanilloid receptor ligands (2015-05-12),

10. 8946290 - Combination of selected opioids with muscarine antagonists for treating urinary incontinence (2015-02-03),

11. 8946204 - Substituted phenylureas and phenylamides as vanilloid receptor ligands (2015-02-03),

12. 8937092 - Aryl or N-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands (2015-01-20),

13. 8791268 - Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions (2014-07-29),

14. 8785474 - Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof to treat pain and other conditions (2014-07-22),

15. 8765733 - Amine substituted methanesulfonamide derivatives as vanilloid receptor ligands (2014-07-01),

Title: The Innovative Journey of Thomas Christoph

Introduction: Thomas Christoph, a visionary inventor hailing from Aachen, Germany, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Thomas Christoph's latest patents include a cutting-edge software application for optimizing energy consumption in smart homes and a revolutionary medical device for non-invasive monitoring of vital signs.

Career Highlights: With over two decades of experience in the tech industry, Thomas Christoph has a proven track record of developing innovative solutions that have improved efficiency and enhanced user experience. His work has been recognized with several prestigious awards, solidifying his reputation as a pioneer in his field.

Collaborations: Throughout his career, Thomas Christoph has collaborated with leading research institutions and tech companies to bring his ideas to life. His ability to work seamlessly in multidisciplinary teams has led to the successful implementation of several groundbreaking projects.

Conclusion: Thomas Christoph's relentless passion for innovation and his unwavering commitment to pushing the boundaries of technology continue to inspire the next generation of inventors. His impact on the industry is undeniable, and his legacy is sure to endure for years to come.